For more information on DDW 2019, please refer to https://ddw.org/home.
About Vanda
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on
Investor Contact:
Executive Vice President & Chief Financial Officer
(202) 734-3428
jim.kelly@vandapharma.com
Media Contacts:
AJ Jones II
202-530-0400
pr@vandapharma.com
212-614-3881
pr@vandapharma.com
View original content:http://www.prnewswire.com/news-releases/tradipitant-in-the-treatment-of-gastroparesis-vanda-presents-clinical-trial-results-at-ddw-2019-300855295.html
SOURCE